These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 33411730)

  • 1. Pomalidomide restores immune recognition of primary effusion lymphoma through upregulation of ICAM-1 and B7-2.
    Shrestha P; Davis DA; Jaeger HK; Stream A; Aisabor AI; Yarchoan R
    PLoS Pathog; 2021 Jan; 17(1):e1009091. PubMed ID: 33411730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunomodulatory drugs target IKZF1-IRF4-MYC axis in primary effusion lymphoma in a cereblon-dependent manner and display synergistic cytotoxicity with BRD4 inhibitors.
    Gopalakrishnan R; Matta H; Tolani B; Triche T; Chaudhary PM
    Oncogene; 2016 Apr; 35(14):1797-810. PubMed ID: 26119939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CK1α and IRF4 are essential and independent effectors of immunomodulatory drugs in primary effusion lymphoma.
    Patil A; Manzano M; Gottwein E
    Blood; 2018 Aug; 132(6):577-586. PubMed ID: 29954751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genome-wide CRISPR screens reveal genetic mediators of cereblon modulator toxicity in primary effusion lymphoma.
    Patil A; Manzano M; Gottwein E
    Blood Adv; 2019 Jul; 3(14):2105-2117. PubMed ID: 31300418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Restoration of immune surface molecules in Kaposi sarcoma-associated herpes virus infected cells by lenalidomide and pomalidomide.
    Davis DA; Mishra S; Anagho HA; Aisabor AI; Shrestha P; Wang V; Takamatsu Y; Maeda K; Mitsuya H; Zeldis JB; Yarchoan R
    Oncotarget; 2017 Aug; 8(31):50342-50358. PubMed ID: 28881567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repurposing Cytarabine for Treating Primary Effusion Lymphoma by Targeting Kaposi's Sarcoma-Associated Herpesvirus Latent and Lytic Replications.
    Gruffaz M; Zhou S; Vasan K; Rushing T; Michael QL; Lu C; Jung JU; Gao SJ
    mBio; 2018 May; 9(3):. PubMed ID: 29739902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pomalidomide increases immune surface marker expression and immune recognition of oncovirus-infected cells.
    Davis DA; Shrestha P; Aisabor AI; Stream A; Galli V; Pise-Masison CA; Tagawa T; Ziegelbauer JM; Franchini G; Yarchoan R
    Oncoimmunology; 2019; 8(2):e1546544. PubMed ID: 30713808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CDK4/6 inhibitors sensitize gammaherpesvirus-infected tumor cells to T-cell killing by enhancing expression of immune surface molecules.
    Wu Y; Shrestha P; Heape NM; Yarchoan R
    J Transl Med; 2022 May; 20(1):217. PubMed ID: 35562811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Daratumumab induces cell-mediated cytotoxicity of primary effusion lymphoma and is active against refractory disease.
    Shrestha P; Astter Y; Davis DA; Zhou T; Yuan CM; Ramaswami R; Wang HW; Lurain K; Yarchoan R
    Oncoimmunology; 2023; 12(1):2163784. PubMed ID: 36632565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altering the Anti-inflammatory Lipoxin Microenvironment: a New Insight into Kaposi's Sarcoma-Associated Herpesvirus Pathogenesis.
    Chandrasekharan JA; Huang XM; Hwang AC; Sharma-Walia N
    J Virol; 2016 Dec; 90(24):11020-11031. PubMed ID: 27681120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism and therapeutic implications of pomalidomide-induced immune surface marker upregulation in EBV-positive lymphomas.
    Jaeger HK; Davis DA; Nair A; Shrestha P; Stream A; Yaparla A; Yarchoan R
    Sci Rep; 2023 Jul; 13(1):11596. PubMed ID: 37463943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A viral protein that selectively downregulates ICAM-1 and B7-2 and modulates T cell costimulation.
    Coscoy L; Ganem D
    J Clin Invest; 2001 Jun; 107(12):1599-606. PubMed ID: 11413168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multi-targeted therapy of everolimus in Kaposi's sarcoma associated herpes virus infected primary effusion lymphoma.
    Mohanty S; Kumar A; Das P; Sahu SK; Choudhuri T
    Apoptosis; 2017 Sep; 22(9):1098-1115. PubMed ID: 28653223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quercetin induces apoptosis and autophagy in primary effusion lymphoma cells by inhibiting PI3K/AKT/mTOR and STAT3 signaling pathways.
    Granato M; Rizzello C; Gilardini Montani MS; Cuomo L; Vitillo M; Santarelli R; Gonnella R; D'Orazi G; Faggioni A; Cirone M
    J Nutr Biochem; 2017 Mar; 41():124-136. PubMed ID: 28092744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The intertransmembrane region of Kaposi's sarcoma-associated herpesvirus modulator of immune recognition 2 contributes to B7-2 downregulation.
    Kajikawa M; Li PC; Goto E; Miyashita N; Aoki-Kawasumi M; Mito-Yoshida M; Ikegaya M; Sugita Y; Ishido S
    J Virol; 2012 May; 86(9):5288-96. PubMed ID: 22379101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pyrrolidinium fullerene induces apoptosis by activation of procaspase-9 via suppression of Akt in primary effusion lymphoma.
    Watanabe T; Nakamura S; Ono T; Ui S; Yagi S; Kagawa H; Watanabe H; Ohe T; Mashino T; Fujimuro M
    Biochem Biophys Res Commun; 2014 Aug; 451(1):93-100. PubMed ID: 25063029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of Cellular CpG DNA Methylation by Kaposi's Sarcoma-Associated Herpesvirus.
    Journo G; Tushinsky C; Shterngas A; Avital N; Eran Y; Karpuj MV; Frenkel-Morgenstern M; Shamay M
    J Virol; 2018 Aug; 92(16):. PubMed ID: 29899086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Triptolide decreases expression of latency-associated nuclear antigen 1 and reduces viral titers in Kaposi's sarcoma-associated and herpesvirus-related primary effusion lymphoma cells.
    Long C; Guo W; Zhou H; Wang J; Wang H; Sun X
    Int J Oncol; 2016 Apr; 48(4):1519-30. PubMed ID: 26821279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arctigenin induces the apoptosis of primary effusion lymphoma cells under conditions of glucose deprivation.
    Baba Y; Shigemi Z; Hara N; Moriguchi M; Ikeda M; Watanabe T; Fujimuro M
    Int J Oncol; 2018 Feb; 52(2):505-517. PubMed ID: 29207179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Azidothymidine Sensitizes Primary Effusion Lymphoma Cells to Kaposi Sarcoma-Associated Herpesvirus-Specific CD4+ T Cell Control and Inhibits vIRF3 Function.
    Williamson SJ; Nicol SM; Stürzl M; Sabbah S; Hislop AD
    PLoS Pathog; 2016 Nov; 12(11):e1006042. PubMed ID: 27893813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.